APA (7th ed.) Citation

Aydos, D., Aksoy, Z. B., Unal, M. A., Akcali, K. C., Bitirim, C. V., & Turan, B. (2025). The dual GLP-1 and GIP receptor agonist tirzapetide provides an unintended interaction with the β-adrenoceptors and plays a role in glucose metabolism in hyperglycemic or senescent cardiac cells. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02828-z

Chicago Style (17th ed.) Citation

Aydos, Dunya, Zeynep Busra Aksoy, Mehmet Altay Unal, Kamil Can Akcali, Ceylan Verda Bitirim, and Belma Turan. "The Dual GLP-1 and GIP Receptor Agonist Tirzapetide Provides an Unintended Interaction with the β-adrenoceptors and Plays a Role in Glucose Metabolism in Hyperglycemic or Senescent Cardiac Cells." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02828-z.

MLA (9th ed.) Citation

Aydos, Dunya, et al. "The Dual GLP-1 and GIP Receptor Agonist Tirzapetide Provides an Unintended Interaction with the β-adrenoceptors and Plays a Role in Glucose Metabolism in Hyperglycemic or Senescent Cardiac Cells." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02828-z.